Skip to main content
Premium Trial:

Request an Annual Quote

Senate Subcommittee Proposes 5.4 Percent Boost to 2019 NIH Budget

NEW YORK (GenomeWeb) – A US Senate subcommittee today called for a $2 billion boost to the fiscal 2019 budget of the National Institute of Health, representing a 5.4 percent increase over the agency's fiscal 2018 budget.

In its funding bill, the Senate Labor, Health and Human Services, and Education appropriations subcommittee recommended raising the NIH's budget to $39.1 billion from its current $37.1 billion. This increase includes an additional $425 million for Alzheimer's research for a total of $2.3 billion; $429.4 million for the BRAIN initiative, a $29 million increase; and $376 million for the All of Us precision medicine study, $86 million more than in FY 2018.

The bill also provides $90.1 billion in discretionary funding for the Department of Health and Human Services, a $2.3 billion increase over FY 2018, and $711 million in funding for the 21st Century Cures Act.

"I'm proud we were able to provide the fourth consecutive funding increase for the National Institutes of Health, which will pave the way for new medical breakthroughs and lower health care costs over the long term," Senator Roy Blunt (R-Mo.), head of the appropriations subcommittee, said in a statement.

The full Senate appropriations committee is set to review the bill on Thursday.

Earlier this month, the House appropriations committee released a draft funding bill that included an increase of roughly 3 percent in NIH funding for fiscal 2019 to $38.3 billion.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.